DRL, RDIF commence clinical trials for Sputnik V Covid-19 vaccine in India ...Middle East

Business Standard - Economy
DRL, RDIF commence clinical trials for Sputnik V Covid-19 vaccine in India
Dr Reddy's Laboratories and Russian Direct Investment Fund (RDIF) on Tuesday said they have commenced adaptive phase 2/3 clinical trials for the Sputnik V COVID-19 vaccine in India. The trials have commenced after receiving the necessary clearance from the Kasauli-based Central Drugs Laboratory, they added. This will be a multicentre and randomised controlled study, which will include safety and immunogenicity study, the Hyderabad-based drug maker and RDIF said in a joint statement. The clinical trials are being conducted by JSS Medical Research as the clinical research partner. Further, Dr Reddy's has partnered with the Biotechnology Industry Research Assistance Council (BIRAC), Department

Read More Details
Finally We wish PressBee provided you with enough information of ( DRL, RDIF commence clinical trials for Sputnik V Covid-19 vaccine in India )

Apple Storegoogle play

Also on site :



Latest News